2025-04-30T07:29:00-05:00 2024-12-31 823736106 POZERSKI HATCH & COMPANY 100 LEDGEWOOD PLACE SUITE 304 ROCKLAND MA 02370 990 2024-01-01 201945347 NEUROENDOCRINE TUMOR RESEARCH FOUNDATION NEUR 6179461780 100 HANCOCK ST THIRD FLOOR QUINCY MA 02171 ELYSE GELLERMAN CHIEF EXECUTIVE OFFICER 6179461780 2025-04-25 1 0 MICHELLE HATCH P01222458 7814801430 2025-04-09 2024 2025-03-06 01:10:19Z X ELYSE GELLERMAN 100 HANCOCK ST THIRD FLOOR QUINCY MA 02171 5345762 0 X NETRF.ORG X 2004 MA TO FUND RESEARCH TO DISCOVER CURES & MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE AFFECTED BY NEURENDOCRINE CANCER BY PROVIDING INFORMATION & EDUCATIONAL RESOURCES. 12 12 7 14 0 0 2558610 3111689 0 0 637647 855797 0 26171 3196257 3993657 2110000 2219056 0 0 1024785 1019619 0 0 492545 445688 539802 3580473 3778477 -384216 215180 20633243 21377613 5100489 4541212 15532754 16836401 TO FUND RESEARCH TO DISCOVER CURES AND MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE AFFECTED BY NEUROENDOCRINE CANCER BY PROVIDING INFORMATION & EDUCATIONAL RESOURCES. 0 0 2508191 2110008 26171 THE NEUROENDOCRINE TUMOR RESEARCH FOUNDATION FUNDS SCIENTIFIC RESEARCH AROUND THE WORLD TO DISCOVER THE CAUSES, IMPROVE TREATMENTS, AND FIND CURES FOR NEUROENDOCRINE CANCER. 391343 NETRF PROVIDES EDUCATION AND SUPPORT FOR PEOPLE WITH NEUROENDOCRINE CANCER AND THEIR FAMILIES. THROUGH EDUCATIONAL CONFERENCES, A PATIENT GUIDE, PODCASTS AND A COMPREHENSIVE WEBSITE, NETRF HELPS PATIENTS UNDERSTAND THEIR DIAGNOSIS AND TREATMENT OPTIONS. 92938 NETRF CONDUCTS OUTREACH TO OTHER NET-RELATED ORGANIZATIONS IN THE UNITED STATES AND BEYOND TO CONVENE RESEARCHERS AND FACILITATE SCIENTIFIC COLLABORATION. THROUGH ITS WORK AND LEADERSHIP WITH THESE OTHER GROUPS, NETRF ADVANCES UNDERSTANDING OF NEUROENDOCRINE TUMORS AND THE NEEDS OF NET PATIENTS. NETRF ALSO WORKS WITH PATIENT SUPPORT GROUPS TO CONNECT TO THE LARGER NET COMMUNITY. 2992472 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 11 0 7 1 0 0 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 MA CA NY X X ELYSE GELLERMAN 6179461780 100 HANCOCK STREET 3RD FLOOR QUINCY MA 02171 MARK LEWIS MD DIRECTOR 4.00 X 0 0 0 JONATHAN SOROFF UNTIL 012024 DIRECTOR 4.00 X 0 0 0 JULIE SHAFFER MEBANE VICE PRESIDENT 4.00 X X 0 0 0 LAURIE RAINS DIRECTOR 4.00 X 0 0 0 ANTHONY DETRE DIRECTOR 4.00 X 0 0 0 STEPHEN BLACKWOOD PHD DIRECTOR 4.00 X 0 0 0 STEPHEN KAUFER DIRECTOR 4.00 X 0 0 0 JOSH MAILMAN TREASURER 4.00 X X 0 0 0 JOSEPH LI MD DIRECTOR 4.00 X 0 0 0 BRENDAN FOLEY UNTIL 62024 SECRETARY 4.00 X X 0 0 0 TODD GILMAN PRESIDENT 4.00 X X 0 0 0 SUZANNE LUDLOW SECRETARY 4.00 X X 0 0 0 LAURIE LITTLEPAGE DIRECTOR 4.00 X 0 0 0 CARRIE CAMINO AS OF 42024 DIRECTOR 4.00 X 0 0 0 ELYSE GELLERMAN CHIEF EXECUTIVE OFFICER 40.00 X 199006 0 0 SUSAN HARRINGTON CHIEF DEVELOPMENT OFFICER 40.00 X 179000 0 491 ANNA GREENE DIRECTOR OF RESEARCH 40.00 X 137064 0 0 JESSICA THOMAS DIRECTOR OF PATIENT EDUCATION 40.00 X 112109 0 20162 CHRISTINA COFFEY UNTIL 072024 DIRECTOR OF COMMUNICATIONS 1.00 X 107547 0 5017 734726 0 25670 5 0 1 0 0 3111689 106442 3111689 561216 561216 1646686 1352105 294581 294581 294581 RETURNED RESEARCH GRANT 900099 26171 26171 26171 3993657 26171 0 855797 1859056 1859056 360000 360000 199006 75622 85573 37811 710038 384716 49004 276318 31726 18684 4702 8340 78849 36102 18164 24583 6116 6116 49037 49037 46689 46689 174432 115619 58813 1656 540 1116 31090 835 2956 27299 34077 3505 12949 17623 87732 40609 19568 27555 28867 16979 2567 9321 125790 124446 1344 7940 3567 1951 2422 DUES AND LICENSES 900 600 300 GRANT DISCOUNTS -54524 -54524 3778477 2992472 293460 492545 1352806 1509614 203802 103845 513268 990391 17417 27629 18457571 18733446 88379 12688 20633243 21377613 217211 233620 4799915 4301399 83363 6193 5100489 4541212 X 2848405 1933297 12684349 14903104 15532754 16836401 20633243 21377613 215180 1088467 0 X 0 1 X 1 0 X 3999607 7368975 2437822 2558610 3111689 19476703 3999607 7368975 2437822 2558610 3111689 19476703 6250450 13226253 418284 492550 427944 533005 561216 2432999 21909702 0.60370 0.52330 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 11867957 1492738 31545 13329150 10188223 1706558 26824 11867957 12224364 -2008960 27181 10188223 6394260 5000000 843131 13027 12224364 5557120 846928 9788 6394260 1.00000 0 0 0 OPERATING LEASE LIABILITY 6193 6193 5035435 1088467 1088467 3946968 46689 46689 3993657 3731788 0 3731788 46689 46689 3778477 PART V, LINE 4: THE ENDOWMENT FUND IS TO BE MAINTAINED IN PERPETUITY AND WAS ESTABLISHED TO SUPPORT THE ACHIEVEMENT OF THE ORGANIZATION'S MISSION. 0 0 0 0 0 0 0 0 0 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES RESEARCH 270000 ELECTRONIC WIRE 0 EAST ASIA AND THE PACIFIC RESEARCH 90000 ELECTRONIC WIRE 0 2 0 0 0 0 0 0 0 X X X 1 STEPHEN PERNA 350 HARRISON AVE APT 704 BOSTON MA 02118 DEVELOPMENT CONSULTING 0 0 17964 -17964 17964 -17964 MA CA NY 0 NORTH AMER NEUROENDOCRINE TUMOR SOCIETY 136 EVERETT RD ALBANY NY 12205 205543641 501 (C) (3) 100000 0 RESEARCH EDUCATION AND RESEARCH FOUNDATION 14301 FNB PARKWAY SUITE 100 OMAHA NE 68144 237048300 501 (C) (3) 100000 0 RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 746001118 501 (C) (3) 270000 0 RESEARCH UTHEALTH HOUSTON 7000 FANNIN UCT 1006 HOUSTON TX 77030 741761309 501 (C) (3) 100000 0 RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02215 042263040 501 (C) (3) 270000 0 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 042697983 501 (C) (3) 270000 0 RESEARCH BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVE BOSTON MA 02215 042103881 501 (C) (3) 19056 0 RESEARCH THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 450 JANE STANFORD WAY STANFORD CA 94305 941156365 501 (C) (3) 270000 0 RESEARCH UNIVERSITY OF IOWA 105 JESSUP HALL IOWA CITY IA 52242 426004813 501 (C) (3) 270000 0 RESEARCH STANFORD UNIVERSITY SCHOOL OF MEDICINE 450 JANE STANFORD WAY STANFORD CA 94305 941156365 501 (C) (3) 100000 0 RESEARCH DAVID GEFFEN SCHOOL OF MEDICINE AT UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BLVD LOS ANGELES CA 90024 956006143 501 (C) (3) 90000 0 RESEARCH 11 0 X X 1 0 0 0 0 0 0 1 0 ELYSE GELLERMAN CHIEF EXECUTIVE OFFICER 174362 0 24644 0 0 0 0 0 0 0 199006 0 0 0 SUSAN HARRINGTON CHIEF DEVELOPMENT OFFICER 157880 0 21120 0 0 0 0 0 491 0 179491 0 0 0 PART I, LINE 4A CHRISTINE COFFEY WAS PAID SEVERANCE IN THE AMOUNT OF $8,556. PART I, LINE 7 BONUSES ARE GIVEN BASED ON THE ACHIEVEMENT OF APPROVED, MEASURABLE GOALS SET ON AN ANNUAL BASIS FOR EACH ELIGIBLE EMPLOYEE. X 4 106442 FMV 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE COMMITEE REVIEWS AND APPROVES THE FORM 990. ALL BOARD MEMBERS RECEIVE AND REVIEW THE 990 BEFORE IT IS SUBMITTED. FORM 990, PART VI, SECTION B, LINE 12C ALL DIRECTORS AND KEY EMPLOYEES ARE REQUIRED TO SIGN OFF THAT THEY HAVE REVIEWED AND DISCLOSED ANY CONFLICTS OF INTEREST, IF ANY, AT LEAST ANNUALLY. THE DIRECTORS REVIEW THESE SIGN-OFFS AND COMMENTS, IF ANY. FORM 990, PART VI, SECTION B, LINE 15A CHIEF EXECUTIVE OFFICER COMPENSATION AND RELATED BENEFITS ARE REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS. THE CHIEF EXECUTIVE OFFICER REVIEWS AND APPROVES STAFF COMPENSATION ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, THE CONFLICT OF INTEREST POLICY AND ANNUAL FINANCIAL STATEMENTS ARE POSTED ON THE ORGANIZATION WEBSITE.